Immunogenicity and Safety of a Tetravalent Dengue Vaccine Administered Concomitantly or Sequentially With Gardasil®

Clinical trial NCT02993757 · COMPLETED

Trial details

NCT number: NCT02993757
Sponsor: Sanofi Pasteur, a Sanofi Company
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Dengue Fever Dengue Hemorrhagic Fever Human Papillomavirus Disease

Start date: 2016-12-01
Primary completion: 2019-05-27
Enrollment: 528

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.